Format

Send to

Choose Destination
Dig Endosc. 2019 May;31(3):291-298. doi: 10.1111/den.13300. Epub 2018 Dec 18.

Endoscopic ultrasound-guided choledochoduodenostomy using a thin stent delivery system in patients with unresectable malignant distal biliary obstruction: A prospective multicenter study.

Author information

1
Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
2
Department of Gastroenterology and Hepatology, Osaka, Japan.
3
Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan.
4
Clinical Research Center, Kindai University Faculty of Medicine, Osaka, Japan.

Abstract

BACKGROUND AND AIM:

When endoscopic retrograde cholangiopancreatography (ERCP) fails in patients with malignant distal biliary obstruction, endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) is an alternative. It has high technical and clinical success rates, but also has high adverse event rates. This prospective cohort study was aimed to evaluate the clinical efficacy and safety of EUS-CDS with our newly developed partially covered self-expandable metal stent with a thin delivery system.

METHODS:

Patients consisted of all consecutive patients in three tertiary referral centers with unresectable malignant distal obstruction in whom ERCP failed and in whom EUS-CDS with the thin delivery system was selected as the second-line approach. Rates of clinical success, technical success, technical success in cases not requiring fistulous tract dilation, adverse events, and stent dysfunction were determined.

RESULTS:

In the 20 patients, technical and clinical success rates were 95.0% (19/20) and 100% (19/19), respectively. In 31.6% (6/19), the delivery system was successfully inserted into the bile duct without requiring a fistulous-tract dilatation device. These patients had significantly shorter procedure times than patients requiring fistulous-tract dilatation (12.7 ± 3.1 vs 23.2 ± 2.1 min; P < 0.01). One patient (5.0%) who required fistulous dilation had an adverse event, which was managed conservatively. There were no procedure-related deaths. During follow up, four patients (21.1%) developed stent dysfunction. Reintervention was successful in all cases.

CONCLUSIONS:

The EUS-CDS approach had 95% technical and 100% clinical success rates, with adverse events reported in 5% of cases. EUS-CDS may become safer if efforts are made to avoid the dilation step (UMIN 000023938).

KEYWORDS:

endoscopic ultrasound-guided biliary drainage; endoscopic ultrasound-guided choledochoduodenostomy; failed endoscopic retrograde cholangiopancreatography; malignant distal biliary obstruction; metal stent with a thin delivery system

PMID:
30444543
DOI:
10.1111/den.13300

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center